Page last updated: 2024-08-21

chenodeoxycholic acid and alitretinoin

chenodeoxycholic acid has been researched along with alitretinoin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Carotti, A; Colliva, C; De Franco, F; Filipponi, P; Franco, P; Gadaleta, RM; Gioiello, A; Macchiarulo, A; Moschetta, A; Mostarda, S; Passeri, D; Pellicciari, R; Roda, A1
Heitel, P; Kalinowsky, L; Merk, D; Proschak, E1
Boulias, K; Kardassis, D; Papakosta, P; Roussou, A; Talianidis, I; Zannis, VI1
Baller, JF; Faber, KN; Geuken, M; Heegsma, J; Hoeke, MO; Jansen, PL; Kuipers, F; Moshage, H; Plass, JR; van Rijsbergen, D1

Reviews

1 review(s) available for chenodeoxycholic acid and alitretinoin

ArticleYear
Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery.
    Journal of medicinal chemistry, 2017, 07-13, Volume: 60, Issue:13

    Topics: Animals; Cyclooxygenase Inhibitors; Drug Discovery; Fatty Acids; Humans; Inflammation; Models, Molecular

2017

Other Studies

4 other study(ies) available for chenodeoxycholic acid and alitretinoin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Discovery of 3α,7α,11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders.
    Journal of medicinal chemistry, 2016, Oct-13, Volume: 59, Issue:19

    Topics:

2016
Synergism between nuclear receptors bound to specific hormone response elements of the hepatic control region-1 and the proximal apolipoprotein C-II promoter mediate apolipoprotein C-II gene regulation by bile acids and retinoids.
    The Biochemical journal, 2003, Jun-01, Volume: 372, Issue:Pt 2

    Topics: Alitretinoin; Animals; Antineoplastic Agents; Apolipoprotein C-II; Apolipoproteins C; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Blotting, Western; Chenodeoxycholic Acid; Chloramphenicol O-Acetyltransferase; Chlorocebus aethiops; COS Cells; Dimerization; DNA Primers; DNA-Binding Proteins; Drug Synergism; Electrophoretic Mobility Shift Assay; Gastrointestinal Agents; Gene Expression Regulation; Hepatocyte Nuclear Factor 4; Humans; Liver Neoplasms; Luciferases; Phosphoproteins; Plasmids; Promoter Regions, Genetic; Receptors, Retinoic Acid; Receptors, Thyroid Hormone; Regulatory Sequences, Nucleic Acid; Retinoid X Receptors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Deletion; Thyroid Hormone Receptors beta; Transcription Factors; Transcriptional Activation; Tretinoin

2003
Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters.
    Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:1

    Topics: Alitretinoin; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Carcinoma, Hepatocellular; Cell Line, Tumor; Chenodeoxycholic Acid; Cholic Acid; DNA-Binding Proteins; Gene Expression Regulation; Humans; Male; Mice; Mice, Inbred C57BL; Organic Anion Transporters, Sodium-Dependent; Receptors, Cytoplasmic and Nuclear; Response Elements; Retinoid X Receptor alpha; Symporters; Transcription Factors; Tretinoin; Vitamin A; Vitamin A Deficiency

2009